ExLibris header image
SFX Logo
Title: Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)
Source:

Pharmacogenomics Journal [1470-269X] Chhibber, A yr:2014


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Yun, Joon K. "A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer." European journal of cancer 46.5 (2010): 885-891. Link to SFX for this item
2. Oates, D. "Capecitabine and oxaliplatin for advanced esophagogastric cancer." New England Journal of Medicine, The 358.1 (2007): 36-46. Link to SFX for this item
3. Condon, B R. "Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging." British journal of radiology 54.637 (1981): 18-23. Link to SFX for this item
4. Monsuez, J. "Cardiac side-effects of cancer chemotherapy." International journal of cardiology 144.1 (2010): 3-15. Link to SFX for this item
5. Kang, D-B I. "Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial." Annals of Oncology 20.4 (2009): 666-73. Link to SFX for this item
6. Okines, A F C F. "Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer." Annals of Oncology 20.9 (2009): 1529-1534. Link to SFX for this item
7. Bang, Y. "Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial." The Lancet 376.9742 (2010): 687-697. Link to SFX for this item
8. Koizumi, W. "Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)." Annals of Oncology 21.5 (2009): 1001-1005. Link to SFX for this item
9. Orditura, M. "Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot study." Archives of surgery 145.3 (2010): 233-238. Link to SFX for this item
10. Thompson, Yu Jo J. "Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer." New England Journal of Medicine, The 355.1 (2006): 11-20. Link to SFX for this item
11. Binkley, Jill M. "Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer." Cancer 118.8 (2012): 2207-2216. Link to Full Text for this item Link to SFX for this item
12. Partridge, Ann H. "Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.(Abstract)." Journal of the National Cancer Institute (2001): 135-. Link to SFX for this item
13. Senkus, E. "Cardiovascular effects of systemic cancer treatment." Cancer treatment reviews 37.4 (2010): 300-311. Link to SFX for this item
14. Lee, J. "A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma." Cancer chemotherapy and pharmacology 62.1 (2008): 77-84. Link to Full Text for this item Link to SFX for this item
15. Comella, B. "Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401." Journal of Cancer Research & Clinical Oncology 135.2 (2009): 217-26. Link to Full Text for this item Link to SFX for this item
16. Gravalos, C. "HER2 in gastric cancer: A new prognostic factor and a novel therapeutic target." Annals of Oncology 19.9 (2008): 1523-1529. Link to SFX for this item
17. Rothenberg, Y-J L. "Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study." Annals of Oncology 19.10 (2008): 1720-6. Link to SFX for this item
18. Clamp A, A. "Assessment of therapeutic response in patients with metastatic bone disease." The lancet oncology 5.10 (2004): 607-616. Link to SFX for this item
19. Wood, P. "Confirmatory Factor Analysis for Applied Research." American Statistician, The 62.1 (2008): 91-92. Link to SFX for this item
20. Chan, S. "Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer." Journal of clinical oncology 17.8 (1999): 2341-54. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.